IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2006;47:4067-4071.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.06-0290

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinna, A.
Right arrow Articles by Carta, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinna, A.
Right arrow Articles by Carta, F.

Plasma Homocysteine and Cysteine Levels in Retinal Vein Occlusion

Antonio Pinna,1 Ciriaco Carru,2 Angelo Zinellu,2 Stefano Dore,1 Luca Deiana,2 and Francesco Carta1

1From the Institute of Ophthalmology and the 2Department of Biochemistry, University of Sassari, Sassari, Italy.

PURPOSE. To determine plasma homocysteine and cysteine levels in patients with retinal vein occlusion (RVO) and in healthy subjects and to ascertain whether there are statistically significant differences between patients and control subjects.

METHODS. In this case–control study, the study group consisted of 75 consecutive patients with RVO: 33 had central retinal vein occlusion (CRVO), and 42 had branch retinal vein occlusion (BRVO). Seventy-two apparently healthy age- and sex-matched subjects served as control subjects. Homocysteine and cysteine levels were measured with a new laser-induced fluorescence capillary electrophoresis (CE-LIF) method. Wilcoxon or Student’s t-test was used, when appropriate, to determine differences between groups.

RESULTS. There were no significant differences in median plasma homocysteine between patients with RVO and control subjects, nor were there any statistically significant differences when patients were categorized by type of vein occlusion (CRVO or BRVO). Similarly, there were no significant differences in mean plasma cysteine between patients with RVO and control subjects. However, when categorized by type of vein occlusion, mean plasma cysteine was significantly higher in CRVO patients than in control subjects (P = 0.034).

CONCLUSIONS. This study failed to demonstrate an association between increased plasma homocysteine and RVO. Mean plasma cysteine was significantly higher in patients with CRVO, suggesting that hypercysteinemia may contribute to the pathogenesis of this retinal vascular disorder.





This article has been cited by other articles:


Home page
IOVSHome page
A. Pinna, C. Carru, G. Solinas, A. Zinellu, and F. Carta
Glucose-6-Phosphate Dehydrogenase Deficiency in Retinal Vein Occlusion
Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2747 - 2752.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology